MAR-METRONIDAZOLE CAPSULE

Land: Canada

Språk: engelsk

Kilde: Health Canada

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
06-08-2019

Aktiv ingrediens:

METRONIDAZOLE

Tilgjengelig fra:

MARCAN PHARMACEUTICALS INC

ATC-kode:

P01AB01

INN (International Name):

METRONIDAZOLE

Dosering :

500MG

Legemiddelform:

CAPSULE

Sammensetning:

METRONIDAZOLE 500MG

Administreringsrute:

ORAL

Enheter i pakken:

100

Resept typen:

Prescription

Terapeutisk område:

MISCELLANEOUS ANTIPROTOZOALS

Produkt oppsummering:

Active ingredient group (AIG) number: 0102572003; AHFS:

Autorisasjon status:

APPROVED

Autorisasjon dato:

2019-08-07

Preparatomtale

                                _Page 1 of 31 _
PRODUCT MONOGRAPH
PR
MAR-METRONIDAZOLE
(Metronidazole Capsules)
Manufacturer’s Standard
500 mg Capsules
Antibacterial - Antiprotozoal
Marcan Pharmaceuticals Inc.
2 Gurdwara Road, Suite #112,
Ottawa, ON, K2E 1A2
Date of Preparation:
August 06, 2019
Submission Control No. 215186
_Page 2 of 31 _
PRODUCT MONOGRAPH
PR
MAR-METRONIDAZOLE
(Metronidazole Capsules)
Manufacturer’s Standard
500 mg Capsules
THERAPEUTIC CLASSIFICATION
Antibacterial - Antiprotozoal
ACTION AND CLINICAL PHARMACOLOGY
Metronidazole is bactericidal against anaerobic bacteria; it exerts
trichomonacidal activity and is
also active against _Giardia lamblia _and _Entamoeba histolytica_. Its
exact mechanism of action has
not been entirely determined as yet. It has been proposed that an
intermediate in the reduction of
metronidazole, produced only in anaerobic bacteria and protozoa is
bound to deoxyribonucleic
acid and electron-transport proteins, inhibits subsequent nucleic acid
synthesis.
INDICATIONS AND CLINICAL USES
PROTOZOAL INFECTIONS
-
Trichomonal infections in men as well as in women.
-
Hepatic and intestinal amebiasis.
-
Giardiasis.
BACTERIAL VAGINOSIS
The “1988 Canadian Guidelines for the Treatment of Sexually
Transmitted Diseases in Neonates,
Children, Adolescents and Adults” recommends metronidazole for the
treatment of this
condition.
BACTERIAL INFECTIONS
Treatment:
Metronidazole is indicated in the treatment of serious anaerobic
intra-abdominal infections due to
susceptible anaerobic bacteria, such as _Bacteroides fragilis _(and
other species of Bacteroides),
_Clostridium_, _Fusobacterium_, _Peptococcus_, and _Peptostreptococcus
species_. In the treatment of
most serious anaerobic infections, intravenous metronidazole is
usually administered initially.
This may be followed by oral therapy with MAR-METRONIDAZOLE capsules
at the discretion
of the physician.
Culture and susceptibility studies should be performed to determine
the causative organisms and
their susceptibility to metronidazole. Based on clinical judgment and
                                
                                Les hele dokumentet
                                
                            

Dokumenter på andre språk

Preparatomtale Preparatomtale fransk 06-08-2019

Søk varsler relatert til dette produktet